STAT February 1, 2024
An inside look at Medicare drug negotiation’s day in court
The post-pandemic world we live in has gotten more friendly to remote hearings and meetings — but not the U.S. District Court of Delaware. So my enterprising colleague John Wilkerson trekked up to Wilmington to give you an inside view on how a key judge viewed arguments in the first court test of the new Medicare drug price negotiation program.
The hearing was called by Colm Connolly, chief judge of the U.S. District of Delaware, in a case brought by AstraZeneca. It’s the first of the slew of lawsuits filed by the pharmaceutical industry and its allies that had an oral argument, and a chance to glean real-time insight from...
Today's Sponsors
Today's Sponsor